SMAD3 rs2033784: Allergy and Asthma Susceptibility
The rs2033784 single nucleotide polymorphism is an intronic regulatory variant located within the SMAD3 gene on chromosome 15. Large genome-wide association studies link this variant to altered susceptibility to allergic conditions, including doctor-diagnosed food allergy, bronchial asthma, and allergic rhinitis. While the effect allele modestly elevates the statistical risk for atopic phenotypes, it functions as a complex susceptibility factor rather than a direct diagnostic marker.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| A/A | Carriers of two copies of the reference A allele display baseline expression of SMAD3. This genotype is associated with standard population-level baseline risk for food allergies, allergic rhinitis, and asthma. It does not carry the elevated statistical risk linked to the minor G allele. | Favorable |
| A/G | Carriers of one A allele and one G allele have an intermediate genetic profile. In genome-wide association studies, this genotype is associated with a modest increase in the odds of developing doctor-diagnosed food allergies, allergic rhinitis, or asthma relative to the A/A baseline. | Informational |
| G/G | Carriers of two copies of the G effect allele exhibit the highest statistical susceptibility observed for this locus regarding atopic diseases and asthma. Research indicates this genotype correlates with reduced SMAD3 expression, although environmental factors strongly influence whether symptoms actually manifest. | Higher attention |
Genomic Location and Variant Biology
The single nucleotide polymorphism rs2033784 is situated on chromosome 15q22.33 within an intronic region of the SMAD3 gene. Rather than altering the primary amino acid sequence of a protein, rs2033784 is characterized as a non-coding regulatory variant. Studies evaluating functional genomics through expression quantitative trait loci (eQTL) datasets, such as the GTEx Portal and eQTLGen Consortium, indicate that the alternate G allele correlates with decreased SMAD3 transcript expression in peripheral whole blood and mucosal tissues. This places rs2033784 in an important class of non-coding variations that influence disease liability by subtly tuning transcriptional output and gene regulation.
The Biological Role of SMAD3 in Immune Signaling
The SMAD3 gene encodes Mothers Against Decapentaplegic Homolog 3, an intracellular signal transducer that operates downstream of the transforming growth factor-beta (TGF-beta) superfamily. TGF-beta/Smad3 signaling is fundamental for maintaining immune tolerance, guiding T regulatory cell differentiation, suppressing inflammatory cascades, and directing tissue repair and airway remodeling. When SMAD3 expression is diminished or its pathway dysregulated, the immune system's normal checkpoint against hypersensitivity can weaken. This molecular vulnerability permits excessive allergic responses to harmless environmental antigens, contributing to hyperreactivity in the respiratory tract and gastrointestinal barrier.
Published Evidence for Allergy and Asthma Associations
Comprehensive genome-wide association studies (GWAS) and meta-analyses have implicated rs2033784 across multiple allergic and atopic phenotypes. Notably, a major meta-analysis published in the Journal of Allergy and Clinical Immunology identified rs2033784 as a lead risk variant for doctor-diagnosed food allergy in adults, with an effect allele frequency of approximately 0.30 in European ancestry cohorts. The variant is in high linkage disequilibrium with other asthma-associated loci across 15q22. Independent pediatric cohort investigations have also detected significant associations with childhood bronchial asthma and allergic sensitization, though some studies suggest that environmental contexts, such as urban living, and sex-specific modifiers can influence the measurable statistical effect size.
Understanding Ancestry and Population Patterns
The distribution of rs2033784 alleles demonstrates meaningful frequency differences across human populations documented in dbSNP and the GWAS Catalog. In populations of European ancestry, the risk-associated G allele displays an allele frequency of roughly 30%, meaning that heterozygous carriers and homozygous individuals make up a substantial proportion of these groups. Because genetic linkage structures, background haplotype architecture, and gene-environment interactions differ widely around the world, the exact odds ratio associated with rs2033784 may not translate identically to non-European ancestry groups. Large-scale multi-ancestry association studies remain essential to refine its effect size globally.
Navigating Results: Clinical Context and Limitations
It is critical to distinguish statistical association from clinical certainty when evaluating rs2033784. Carrying one or two copies of the G allele does not mean an individual has or will develop asthma, food allergies, or allergic rhinitis. Allergic and atopic diseases are classic polygenic conditions shaped by hundreds of genetic variants operating alongside environmental factors like allergen exposure, diet, childhood infections, and air quality. Genetic testing for rs2033784 cannot diagnose an allergy or predict anaphylaxis. Anyone experiencing respiratory symptoms or adverse reactions to foods should consult an allergist or immunologist for validated diagnostic evaluations such as skin prick testing and specific IgE panels.
How common is this variant?
The effect allele (G) has a frequency of approximately 0.30 in individuals of European ancestry, making both heterozygous and homozygous genotypes common in these populations. Allele frequencies and linkage patterns vary in other ancestral groups.
Frequently asked questions
Can rs2033784 tell me if I have a food allergy?
No, rs2033784 is not a diagnostic test and cannot confirm a food allergy. It reflects a modest statistical association observed in population research. Clinical food allergies must be evaluated by a healthcare professional through formal clinical history, IgE antibody tests, or oral food challenges.
What is the biological role of the SMAD3 gene in allergies?
SMAD3 helps mediate the TGF-beta signaling pathway, which is essential for regulating inflammation and maintaining immune system tolerance. Reduced expression or disrupted signaling associated with certain SMAD3 variants can allow inflammatory and allergic pathways to become overactive.
Does having the G allele mean my children will develop asthma?
No. Asthma is a complex, multifactorial disorder caused by the interplay of hundreds of genetic variants and environmental exposures such as viral infections and air quality. Carrying the G allele only slightly shifts statistical risk and is not a deterministic inheritance marker.
Can I use my rs2033784 genotype to adjust asthma or allergy medications?
No, rs2033784 does not provide guidance on medication choices, drug metabolism, or dosage adjustments. Any decisions regarding inhalers, antihistamines, biologics, or allergy immunotherapy should always be made in consultation with your physician or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2033784?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29